Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

From staging to changing strategy: [18F]FDG PET/MRI's impact on treatment planning in early breast cancer.

MRI was highly informative for detecting multifocal disease, whereas the potential added value of [18F]FDG PET/MRI may primarily relate to integrated axillary and distant staging, however, its moderate diagnostic accuracy warrants caution to prevent overtreatment.

R. di Micco, S. P. Corona, V. Bagnardi et al. · 0 citations
Review Open access Oct 2026

Optimizing early identification and management of trastuzumab deruxtecan-related interstitial lung disease: insights from a multidisciplinary expert panel

Proactive surveillance strategies are essential to minimize ILD-related morbidity while preserving access to T-DXd therapy and the implementation of standardized clinical pathways and the development of biomarker-driven approaches may further improve personalized ILD risk management.

L. Licata, C. Lisanti, G. Arpino et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.